Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Cash from Financing Activities (2018 - 2026)

AdaptHealth has reported Cash from Financing Activities over the past 8 years, most recently at -$32.9 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 38.98% year-over-year to -$32.9 million; the TTM value through Dec 2025 reached -$302.2 million, down 51.89%, while the annual FY2025 figure was -$302.2 million, 51.89% down from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$32.9 million at AdaptHealth, up from -$56.6 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $1.2 billion in Q1 2021 and troughed at -$156.6 million in Q2 2025.
  • A 5-year average of $47.0 million and a median of -$20.7 million in 2021 define the central range for Cash from Financing Activities.
  • Biggest five-year swings in Cash from Financing Activities: surged 2007.94% in 2021 and later plummeted 458.1% in 2024.
  • Year by year, Cash from Financing Activities stood at -$21.7 million in 2021, then increased by 28.19% to -$15.6 million in 2022, then tumbled by 181.32% to -$43.9 million in 2023, then fell by 23.06% to -$54.0 million in 2024, then surged by 38.98% to -$32.9 million in 2025.
  • Business Quant data shows Cash from Financing Activities for AHCO at -$32.9 million in Q4 2025, -$56.6 million in Q3 2025, and -$156.6 million in Q2 2025.